| Bioactivity | AE-ITU dihydrobromide is the dihydrobromide form of AE-ITU. AE-ITU dihydrobromide is a selective inhibitor for inducible NO synthase (iNOS), and attenuates the liver dysfunction caused by endotoxaemia in rats[1]. |
| In Vivo | AE-ITU dihydrobromide (1 mg/kg/h，静脉注射，持续 1 小时) 可减轻 LPS (HY-D1056) 诱导的 Wistar 大鼠迟发性低血压和血管反应性低下，改善肝功能障碍[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
| CAS | 56-10-0 |
| Formula | C3H11Br2N3S |
| Molar Mass | 281.01 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Thiemermann C, et al., The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol. 1995 Dec;116(7):2845-51. |
AE-ITU dihydrobromide
CAS: 56-10-0 F: C3H11Br2N3S W: 281.01
AE-ITU dihydrobromide is the dihydrobromide form of AE-ITU. AE-ITU dihydrobromide is a selective inhibitor for inducible
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.